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Gene network analysis and design
Matthew J. Berrymana , Andrew Allisona and Derek Abbotta
a Centre

for Biomedical Engineering and
School of Electrical and Electronic Engineering,
The University of Adelaide, SA 5005, Australia.
ABSTRACT
Gene networks are composed of many diﬀerent interacting genes and gene products (RNAs and proteins). They
can be thought of as switching regions in n-dimensional space or as mass-balanced signaling networks. Both
approaches allow for describing gene networks with the limited quantitative or even qualitative data available.
We show how these approaches can be used in modeling the apoptosis gene network that has a vital role in
tumor development. The open question is whether engineering changes to this network could be used as a
possible cancer treatment.
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1. INTRODUCTION
While cancer is understood in very broad terms1, 2 and many of the key proteins involved are very well understood,3–5 more research is needed at the gene network level to understand interactions between genes, proteins,
and the environment. p53 is a key protein involved in a number of key cell processes,6 which if disturbed can
lead to cancer.1, 2 By modeling the p53 gene network, we can gain a better understanding of its interactions,
with key implications for cancer treatment.
Modeling gene networks gives us a broad, yet important view of vital cell regulatory functions.7, 8 Two
techniques that have been developed are mass-balanced signaling networks9–11 (of which the Michaelis-Menten
kinetics are a particular form12 ), and piecewise-linear diﬀerential equations (DEs),7, 13, 14 a generalization on
the work in Boolean N K switching networks by Glass and Edwards.14–16 Although enzyme kinematics are a
useful tool,9, 12 the ODEs involved are typically quite stiﬀ which increases the computation time.10 Also, the
piecewise-linear DE approach gives a better picture of the qualitative nature of the behaviour,7 since they are
quick and accurate to integrate14 and good analytical tools exist for their qualitative behaviour.13
Gene networks present several problems for any sort of quantitative analysis.7, 13 Many of the interacting
proteins may be unknown, and even between the known interacting proteins, some of the interactions occur only
under unknown conditions.7 Furthermore, although techniques such as microarrays and reverse transcriptasepolymerase chain reaction (RT-PCR) give gene expression levels,17 there is a lot of variance, a lot of measurement
error, and they do not typically provide enough detail about the complex interactions to establish any strict rules
of behaviour in the gene networks.18 Even in well-established gene networks, such as the p53 network, the details
of many interactions are still being discovered.6 Some of the key ones, such as the feedback loop that exists
between p53 and another protein, Mdm2, are lacking clear quantitative values.6 Consequently, we are left with
an incomplete picture of protein interactions, with imprecise, qualitative rules – for example, protein A binds to
protein B, or protein C activates transcription of protein D. Basing our analysis on logical switching systems is
useful, because:
“logical switching systems capture major features of a homologous class of nonlinear dynamical systems governed by sigmoidal functions because such systems tend to sharpen their responses to extremal values of the
variables.” (Kauﬀman8 )
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If one considers a typical sigmoidal function,
y=
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+ xn

then it is trivial to show that
lim y = lim
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x>θ
x < θ.

(2)

Thus in the extreme case, as n → ∞ we have a simple switching, or step function. Piecewise-linear (PL)
diﬀerential equation (DE) models, originally developed by Glass and Edwards,14–16 oﬀer a way around this
problem, in that they can successfully model systems in a qualitative sense, including quantitative data where
available. Filippov successfully introduced step-functions, which are important for modeling the switch-like
regulatory interactions in gene networks.19

2. METHODS
13

As described by de Jong,

the rates of change of proteins can be written as
ẋ = f (x) − g (x) x

(3)



where x = (x1 , . . . , xn ) , x ∈ Rn≥0 is the expression levels (copy number / volume) of the n proteins, f =

(f1 , . . . , fn ) consists of the rates of synthesis of each proteins, and g (x) = diag (g1 , . . . , g2 ) is the rate of degradation.13 The rate of synthesis of the protein i, fi : R≥0 → {0, 1} depends on the levels of the proteins, x in
some fashion,

fi (x) =
κil bil (x) ,
(4)
l∈L

for rate parameter κil > 0, and bil :
→ {0, 1} a regulation function, and L a possibly empty set of indices
of regulation functions. The gi are deﬁned similarly to the fi , except we require that gi > 0∀i. The regulation
functions bil are deﬁned in terms of step functions s+ , s− : R2 → {0, 1} deﬁned as

1, xj > θj
+
(5)
s (xj , θj ) =
0, xj < θj
Rn≥0

s− (xj , θj ) =1 − s+ (xj , θj )

(6)

We consider a generalized view of the p53 network, as shown in Figure 1. Based on Figure 1, we abstract

over the proteins apart from p53 and Mdm2, instead considering x = (xd , xu , xp , xm , xA , xC , xD ) where xd is
the level of DNA damage kinases, xu the level of UV stress kinases, xp the expression level of p53, xm the level of
Mdm2, xD the combined level of apoptosis (programmed cell death) proteins, xA for the angiogenesis proteins,
and xC for the cell cycle proteins. The network of interactions is shown in Figure 2. We use the following set of
equations to model the p53 network:
xp =spd s+ (xd , θd ) + spu s+ (xu , θu ) + spm s+ (xm , θm ) s− (xp , θp ) − gp xp
+

−

xm =sm s (xm , θm ) s (xp , θp ) − gm xm

(7)
(8)

+

xA =sA s (xp , θA ) − gA xA

(9)

+

xC =sC s (xp , θC ) − gC xC

(10)

+

xD =sD s (xp , θD ) − gD xD ,

(11)

where θa for some protein (or protein group) a is the level at which the protein b in the term scb s± (xc , θa ) signals
for the synthesis of the protein c at rate scb . No equations for xd and xu are given as these are input variables.
We deﬁne θC < θA < θD , which has the interpretation that as a ﬁrst response the cell stops the cell cycle and
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Figure 1. This ﬁgure, by Nakade,20 shows some of the key players in the p53 network, including the p53-Mdm2 feedback
loop. DNA breaks and UV stress cause changes in such kinase proteins as ATM kinase and Casein kinase II. A kinase
is a protein that adds a phosphor atom to a protein. In this case, a phosphor atom is added to p53. p53 is then termed
phosphorylated, and this aﬀects its binding to Mdm2, altering the feedback loop. The increased levels of p53 then can
signal for inhibition of angiogenesis, cell cycle arrest (to allow DNA repair to occur), and/or apoptosis. The actual
response, simply halting or undergoing apoptosis, is a function of the input.

signals for angiogenisis, and with the highest levels of damage and stress undergoes apoptosis (programmed cell
death).
For each output variable, we have a target equilibrium position, which exists in some regulatory domain.
Switching domains exist on the boundaries between regulatory domains. This can be seen in the representation
of the domains for p53 and Mdm2 in Figure 3.
The equilibrium positions and the domains are shown in Table 1. Note that ma is the maximum value of
expression of protein a, denoted by xa . For the output protein levels of interest, we also deﬁne critical values –
if the protein level xA lies above the critical value cA , then we say protein group A is activated, that is the cell
would then be signaling for angiogenesis. These are the primary domains used for our analysis, however we have
an alternate set to see what happens if we can reduce the level of p53 produced in response to various stress
levels. These are shown in Table 2. We also need a set of initial conditions. Because this is a qualitative model,
it is suﬃcient to simply specify regulatory domains for the initial conditions. We are interested in four diﬀerent
cases,
1. (xd , xu ) ∈ [0, θd ) × [0, θu ),
2. (xd , xu ) ∈ [0, θd ) × (θu , mu ],
3. (xd , xu ) ∈ (θd , md ] × [0, θu ], and
4. (xd , xu ) ∈ (θd , md ] × (θu , mu ],
corresponding to varying stresses on the cell; the ﬁrst one corresponding to no DNA damage or UV stress. In
addition, we must also specify the initial conditions for the other variables, these are kept constant as shown in
Table 3.
x ∈ (a, b) means a < x < b, x ∈ (a, b] means a < x ≤ b, x ∈ [a, b) means a ≤ x < b and x ∈ [a, b] means a ≤ x ≤ b
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Figure 2. This network shows with directed arrows the inﬂuences of various inputs and proteins on other proteins. UV
stress (denoted by u) and DNA damage (d) signal for production of p53, which is in a feedback loop with the Mdm2
protein. Downstream targets of p53 include proteins that signal for angiogeneis (a), halting of the cell cycle (c), and
apoptosis (programmed cell death, denoted by d).

Figure 3. The set of protein expression values (xp , xm ) ∈ [0, mp ] × [0, mm ] can be drawn as a 2D plane, with points lying
either in switching domains, the lines at critical values (θ’s), and the regulatory domains (lying between critical values).
As the level of p53 (xp ) increases, it shifts in to diﬀerent signaling domains. For example if xp lies in the range (θC , θA )
it means that cell-cycle halting is being signaled for, but not angiogenesis or apoptosis.
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Table 1. The equilibrium position(s) for each output protein level, and the regulatory domains that have been speciﬁed
for these to occur in. There are several p53 equilibrium positions – one for each combination of synthesis/binding rates,
the others have only one synthesis rate so only one equilibrium position occurs, according to the theorems in de Jong.13

Variable
xp
xp
xp
xp
xp
xp
xp
xm
xC
xA
xD

Equilibrium position
(spd + spu ) /gp
(spd + spu + spm ) /gp
spd /gp
(spd + spm ) /gp
spu /gp
(spu + spm ) /gp
spm /gp
sm /gm
sC /gC
sA /gA
sD /gD

Regulatory Domain
(θD , mm ]
(θD , mm ]
(θA , θD )
(θD , mm ]
(θA , θD )
(θD , mm ]
(θA , θD )
(θm , mm ]
(cC , mC ]
(cA , mA ]
(cD , mD ]

Table 2. Similar to Table 1, we list the lowered equilibrium position(s) for each output protein level, and the regulatory
domains that have been speciﬁed for these to occur in. As discussed previously, p53 has several equilibrium positions
– one for each combination of synthesis/binding rates, the others have only one synthesis rate so only one equilibrium
position occurs, according to the theorems in de Jong.13

Variable
xp
xp
xp
xp
xp
xp
xp
xm
xC
xA
xD

Equilibrium position
(spd + spu ) /gp
(spd + spu + spm ) /gp
spd /gp
(spd + spm ) /gp
spu /gp
(spu + spm ) /gp
spm /gp
sm /gm
sC /gC
sA /gA
sD /gD

Regulatory Domain
(θA , θD )
(θD , mm ]
(θC , θA )
(θA , θD )
(θC , θA )
(θA , θD )
(θC , θA )
(θm , mm ]
(cC , mC ]
(cA , mA ]
(cD , mD ]

Table 3. Initial regulatory domains for p53 (xp ), Mdm2 (xm ), and output signals for the halting of cell cycle (xC ),
angiogenesis (xA ), and apoptosis (xD ).

Variable
xp
xm
xC
xA
xD
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Initial domain
[0, θA ]
[0, mm ]
[0, cC ]
[0, cA ]
[0, cD ]

Figure 4. Graph showing the ﬁnal set of states for the input set one, (xd , xu ) ∈ [0, θd ) × [0, θu ), representing no external
stress on the cell. States denote the proteins being in particular domains, for example Tables 4 denotes the ﬁnal state
S1. The numbering of states is arbitrary. From the initial equilibrium state, the cell can transition through a number
of regulatory (boxed) and switching (not boxed) states and lying in an attractor basis with the ﬁnal equilibrium state in
Table 4 as the attractor. Arrow directions denote allowed state transitions.

3. RESULTS
Each set of initial conditions run through the model produces a set of states that the cell cycles through. We
found that in each case there is a single attractor state that the system settles into, representing the decision of
the cell to either continue normally, halt the cell cycle, signal for angiogenesis, or undergo apoptosis. An example
of the transition diagram is shown in Figure 4. The set of four states, corresponding to the ﬁnal states for each
input 1-4, and the normal equilibrium postions in Table 1 are shown in Tables 4 through 7.
Table 4. Final state for input set one: (xd , xu ) ∈ [0, θd ) × [0, θu ). This represents no external stress on the cell. As
expected, none of its responses are triggered, represented by xa < cA , xC < cC and xD < cD .

Variable
xA
xC
xD
xm
xp

Final domain
[0, cA )
[0, cC )
[0, cD )
[0, θm )
[0, θp )

For the alternate set of equilibrium positions in Table 2, the results are the same, except that when a single
input is present, the system only signals for the cell cycle to be halted and not angiogensis, and making cA < cC
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Table 5. Final state for input set two: (xd , xu ) ∈ [0, θd ) × (θu , mu ]. This represents one external stress on the cell, in this
case UV stress. Two of its responses are triggered, represented by cA < xa ≤ mA , cC < xC ≤ mC and cD < xD ≤ mD .
In words, this means the cell is signaling for angiogenesis, and has halted the cell cycle in order to prevent DNA damage,
but the cell is not under enough pressure to undergo apoptosis.

Variable
xA
xC
xD
xm
xp

Final domain
(cA , mA ]
(cC , mC ]
[0, cD )
θm
(θA , θD )

Table 6. Final state for input set three: (xd , xu ) ∈ (θd , md ] × [0, θu ]. This represents one external stress on the cell, in this
case DNA damage. Two of its responses are triggered, represented by cA < xa ≤ mA , cC < xC ≤ mC and cD < xD ≤ mD .
In words, this means the cell is signaling for angiogenesis, and has halted the cell cycle to repair DNA damage, but the
cell is not under enough pressure to undergo apoptosis.

Variable
xA
xC
xD
xm
xp

Final domain
(cA , mA ]
(cC , mC ]
[0, cD )
θm
(θA , θD )

Table 7. Final state for input set four: (xd , xu ) ∈ (θd , md ] × (θu , mu ]. This represents one external stress on the cell,
in this case DNA damage. Two of its responses are triggered, represented by cA < xa ≤ mA , cC < xC ≤ mC and
cD < xD ≤ mD . In words, this means the cell is so stressed and damaged that it would be too risky for cell division to
occur, which would ﬁx in the genetic changes to its descendants, so it undergoes apoptosis.

Variable
xA
xC
xD
xm
xp

Final domain
(cA , mA ]
(cC , mC ]
[cD , mD )
θm
(θA θD )

reverses that. Also for both inputs being present, the output is that both the cell cycle and angiogenesis are
signaled for, but not apoptosis. This allows potentially harmful mutations to be passed on to daughter cells.

4. CONCLUSIONS
Given a qualitative model of the interactions of the p53 protein in the cell, we are able to design a simpliﬁed gene
network to represent this information. In a qualitative sense this gives the output that is observed in in vivo and
in vitro cells, namely that if not stressed or damaged, the cell undergoes a normal cell cycle and divides. If there
is some damage or stress the cell cycle is halted, and for a signiﬁcant amount of damage and stress the cell does
not divide and pass on its mutations but instead undergoes apoptosis (programmed cell death). Shifting the
equilibrium positions is equivalent to altering the response of the cell; for the example we considered, changing
the equilibrium positions lower means the cell is less likely to signal for appropriate responses, in particular
never undergoing apoptosis. This would mean that potentially harmful (to the organism) mutations are carried
forward into daughter cells upon division of the stressed and damaged cell. Shifting the equilibrium positions
higher means the cell is more likely to halt and repair DNA and undergo apoptosis for higher (yet lower than
normal) levels of DNA damage. This could be a useful response to have in tumors that have not lost the capability
of apoptosis and suggests future treatments could target these equilibrium positions.
In future work, we propose exploring the angiogenesis, cell cycle, and apoptosis pathways in more detail.
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The use of quantitative data where available would allow us to build testable models of cell outputs, although
our existing model agrees with observed qualitative descriptions of cell processes. In addition to exploring more
equilibrium positions and inputs, we can also explore changes to the network. Since many drugs alter the
pathways, we could possibly impact upon drug selection, dosage, and development of new drugs for treating
cancer.
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13. H. de Jong, J.-L. Gouzé, C. Hernandez, M. Page, T. Sari, and J. Geiselmann, “Quantitative simulation of
genetic regulatory networks using piecewise-linear models,” Bulletin of Mathematical Biology 66, pp. 301–
340, 2004.
14. R. Edwards and L. Glass, “Combinatorial explosion in model gene networks,” Chaos 10, pp. 691–704, 2000.
15. L. Glass, “Classiﬁcation of biological networks by their qualitative dynamics,” Journal of Theoretical Biology
54, pp. 85–107, 1975.
16. R. Edwards, “Analysis of continuous-time switching networks,” Physica D 146, pp. 165–199, 2000.
17. D. D. Shoemaker, E. E. Schadt, C. D. Armour, Y. D. He, P. Garrett-Engele, P. D. McDonagh, L. P. M., et al.,
“Experimental annotation of the human genome using microarray technology,” Nature 409, pp. 922–927,
Feb. 2001.
18. Y. Moreau, F. de Smet, G. Thijs, K. Marchal, and B. de Moor, “Functional bioinformatics of microarray
data: from expression to regulation,” Proceedings of the IEEE 90, pp. 1722–1743, Nov. 2002.
19. A. F. Filippov, Diﬀerential equations with discontinuous righthand sides, Kluwer Academic Publishers, 1988.
20. K. Nakade, “The p53 network,” in http://www.brc.riken.jp/lab/dna/en/GENESETBANK/p53 network.html,
2004.

Proc. of SPIE Vol. 5651

133

